Ceftazidime-avibactam/aztreonam combination synergy against carbapenem-resistant Gram-negative isolates: In vitro study

Background: The ceftazidime-avibactam combination is able to inhibit ESBLs, AmpCs and Class A carbapenemases and has been recommended for the treatment of complicated UTIs and ventilator-associated bacterial pneumonia. Aims: The present study was undertaken to evaluate the in vitro activity of cefta...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Reena Rajan, A V Raghavendra Rao, Mathavi Suresh Kumar
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wolters Kluwer Medknow Publications 2024-01-01
Cyfres:	Current Medicine Research and Practice
Pynciau:	carbapenem resistance ceftazidime-avibactam/aztreonam combination disc diffusion gram-negative bacilli synergy
Mynediad Ar-lein:	http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2024;volume=14;issue=1;spage=16;epage=21;aulast=Rajan
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!